The effects of IL-17 on breast cancer can be divided into direct and indirect effects: IL17 could directly change the gene-expression profile and the behavior of nonmetastatic tumor cells, causing tumor growth in vivo [46]; IL-17 may also promote tumor progression by recruiting neutrophils to tumor tissue. This evidence concerns the gene IL17A and breast cancer.